News

The 3 Things That Matter for Moderna Now
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals
Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Moderna Logs Sales Beat Despite Declining Vaccine Demand
Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening ...
IO Biotech says cancer vaccine with Merck’s Keytruda outperformed in late-stage study
IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...
Moderna will lay off 10% of employees, Massachusetts-based company announces
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
The New York Times4y
Moderna's Covid-19 Vaccine, Explained - The New York Times
When Moderna and other vaccine makers began designing mRNA vaccines for coronaviruses, skeptics wondered how well they would work. The two preliminary reports from both Moderna and Pfizer ...
USA Today4y
Moderna COVID vaccine safe, effective in children 12-17 years old
The Moderna vaccine was 93% effective against COVID-19 in children aged 12 to 17 after the first dose and 100% two weeks after the second dose, with no cases of COVID-19 reported among vaccinated ...
CNN3y
Moderna’s vaccine is the most effective, but Pfizer and J&J also ...
A head-to-head study of coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer’s in real-life use in keeping people out of the hospital, and J ...